Macromolecular Research

, Volume 14, Issue 3, pp 387–393 | Cite as

Preparation and characterization of folic acid linked poly(L-glutamate) nanoparticles for cancer targeting

Communications
Received:
Revised:

Abstract

Nanoparticles of Poly(L-glutamic acid) (PG) conjugated to the anticancer drug paclitaxel and targeted moiety folic acid (FA) were synthesized and characterizedin vitro. The nanoparticles were designed to take advantage of FA targeting to folate receptor (FR) positive cancer cells. The chemical composition of the conjugate was characterized by1H-NMR, FTIR and UV/vis spectroscopy. The selective cytotoxicity of the FA-PG-paclitaxel conjugates was evaluated in FR positive cancer cells. The interaction of the conjugate was visualized by fluorescence microscopy with results confirming the successful preparation of the conjugate and the production of nanoparticles of about 200–300 nm in diameter. The amount of paclitaxel conjugated to FA-PG was 25% by weight. Cellular uptake of the conjugate was FA dependent, and the conjugate uptake was mediated specifically by the folate receptor. These results demonstrate the improved selective toxicity and effective delivery of an anticancer drug into FR bearing cellsin vitro.

Keywords

cancer targeting folate receptor nanoparticles PG 
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. (1).
    J. B. Gibbs,Science,287, 1969 (2000).CrossRefGoogle Scholar
  2. (2).
    D. Dube, M. Francis, J.-C. Leroux, and F. M. Winnik,Bioconjugate Chem.,13, 685 (2002).CrossRefGoogle Scholar
  3. (3).
    J. Sudimack and R. J. Lee,Adv. Drug Del. Rev.,41, 147 (2000).CrossRefGoogle Scholar
  4. (4).
    A. Tang, P. Kopeckova, and J. Kopecek,Pharm. Res.,20, 360 (2003).CrossRefGoogle Scholar
  5. (5).
    M. V. Backer and J. M. Backer,Bioconjugate Chem.,12, 1066 (2001).CrossRefGoogle Scholar
  6. (6).
    N. K. Egilmez, Y. S. Jong, M. S. Sabel, J. S. Jacob, E. Mathiowitz, and R. B. Bankert,Cancer Res.,60, 3832 (2000).Google Scholar
  7. (7).
    C. J. Mathias, D. Hubers, P. S. Low, and M. A.Green,Bioconjugate Chem.,11, 253 (2000).CrossRefGoogle Scholar
  8. (8).
    G. F. Rowland, G. J. O’Neill, and D. A. L. Davies,Nature,255, 487 (1975).CrossRefGoogle Scholar
  9. (9).
    J. Vega, S. Ke, Z. Fan, S. Wallace, C. Charsangave, and C. Li,Pharm. Res.,20, 826 (2003).CrossRefGoogle Scholar
  10. (10).
    P. Caliceti, S. Salmaso, A. Semenzato, T. Carofiglio, R. Fornasier, M. Fermeglia, M. Ferrone, and S. Pricl,Bioconjugate Chem.,14, 899 (2003).CrossRefGoogle Scholar
  11. (11).
    S. Wang, R. J. Lee, C. J. Mathias, M. A. Green, and P. S. Low,Bioconjugate Chem.,7, 56 (1996).CrossRefGoogle Scholar
  12. (12).
    K. Y. Lee,Macromol. Res.,13, 542 (2005).CrossRefGoogle Scholar
  13. (13).
    L. L. Kiessling, J. E.Gestwicki, and L. E. Strong,Curr. Opin. Chem. Biol.,4, 696 (2000).CrossRefGoogle Scholar
  14. (14).
    M. Mammen, S.-K. Choi, and G. M. Whitesides,Angew. Chem. Int. Ed. Engl.,37, 2754 (1998).CrossRefGoogle Scholar
  15. (15).
    D. M. Spencer, T. J. Wandless, S. L. Schreiber, and G. R. Crabtree,Science,262, 1019 (1993).CrossRefGoogle Scholar
  16. (16).
    C. R. Thomas and P. Bonomi,Curr. Opin. Oncol.,2, 359 (1990).CrossRefGoogle Scholar
  17. (17).
    R. Komaki, J. B. Putnam, and J. D. Shin Cox,Curr. Opin. Oncol.,9, 156 (1997).CrossRefGoogle Scholar
  18. (18).
    C. Li,Adv. Drug. Deliv. Rev.,54, 695 (2002).CrossRefGoogle Scholar
  19. (19).
    C. Li, J. E. Price, L. Milas, N. R. Hunter, S. Ke, D.-F. Yu, C. Charnsangavej, and S. Wallace,Clin. Cancer Res.,5, 891 (1999).Google Scholar
  20. (20).
    R. Duncan,Nature Rev. Drug Discov.,2, 347 (2003).CrossRefGoogle Scholar
  21. (21).
    W. Tansey, S. Ke, X.-Y. Cao, M. J. Pasuelo, S. Wallace, and C. Li,J. Control. Release,94, 39 (2004).CrossRefGoogle Scholar
  22. (22).
    T. J. Deming,Nature,390, 386 (1997).CrossRefGoogle Scholar
  23. (23).
    C. Li, D. F. Yu, R. A. Newman, F. Cabral, L. C. Stephens, N. Hunter, L. Milas, and S. Wallace,Cancer Res.,58, 2404 (1998).Google Scholar
  24. (24).
    C. P. Leamon, S. R. Cooper, and G. E. Hardee,Bioconjugate Chem.,14, 738 (2003).CrossRefGoogle Scholar

Copyright information

© The Polymer Society of Korea and Springer 2006

Authors and Affiliations

  1. 1.Department of Chemical and Biological EngineeringChungju National UniversityChungbukKorea

Personalised recommendations